Cencora, Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Total Revenue $146.8b
$153.1b +4.29%
$167.9b +9.66%
$179.6b +6.94%
$189.9b +5.74%
$214.0b +12.69%
$238.6b +11.50%
$262.2b +9.89%
$294.0b +12.12%
$321.3b +9.31%
$332.8b +3.56%
Cost of Revenue $142.6b
$148.6b +4.22%
$163.3b +9.91%
$174.5b +6.81%
$184.7b +5.88%
$207.0b +12.10%
$230.3b +11.23%
$253.2b +9.95%
$284.0b +12.18%
$309.9b +9.08%
$319.6b +3.13%
Cost of goods sold $142.6b
$148.6b +4.22%
$163.3b +9.91%
$174.5b +6.81%
$184.7b +5.88%
$207.0b +12.10%
$230.3b +11.23%
$253.2b +9.95%
$284.0b +12.18%
$309.9b +9.08%
$319.6b +3.13%
Gross Profit $4.3b
$4.5b +6.40%
$4.6b +1.46%
$5.1b +11.40%
$5.2b +1.04%
$6.9b +33.73%
$8.3b +19.49%
$9.0b +7.99%
$9.9b +10.61%
$11.5b +15.83%
$13.2b +15.18%
Restructuring and other expenses $102.9m $959.3m $183.5m $330.5m $6.8b $471.9m $63.5m $229.9m $233.6m $229.4m
Operating Expenses $7.0b $8.7b
Operating Income (Loss) $1.5b
$1.1b -30.50%
$1.4b +36.15%
$1.1b -22.98%
($5.1b) -561.84%
$2.4b +145.84%
$2.4b +0.52%
$2.3b -1.08%
$2.2b -7.07%
$2.6b +20.84%
$4.5b +72.30%
Interest expense, net $139.9m $145.2m $174.7m $157.8m $137.9m $174.1m $210.7m $228.9m $157.0m $291.5m $511.6m
Foreign Currency Transaction Gain (Loss), before Tax ($3.4m) ($14.4m)
Gain (Loss) Related to Litigation Settlement $133.8m $1.4m $35.9m $145.9m $9.1m $168.8m $1.8m $239.1m $170.9m $236.4m
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement ($47.6m) $0 $0
Nonoperating Income (Expense) $5.0m $2.7m ($25.5m) $13.0m $1.6m $41.7m $27.4m $49.0m ($14.3m) ($78.7m)
Other Expenses $42.5m $33.6m $5.6m
Interest Income (Expense), Nonoperating, Net ($139.9m) ($145.2m) ($174.7m) ($157.8m) ($137.9m) ($174.1m) ($210.7m) ($228.9m) ($157.0m) ($291.5m) $80.2m
Income (Loss) from Continuing Operations before Income Taxes, Domestic $906.4m $394.7m $704.9m $336.1m ($6.0b) $1.5b $1.4b $1.4b $1.3b $1.6b $3.6b
Income before income taxes $1.4b $917.9m $1.2b $967.1m ($5.3b) $2.2b $2.2b $2.2b $2.0b $2.3b $3.6b
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $0 $0 $42.5m $1.2m $9.2m $2.2b $2.2b $2.2b $2.0b $2.3b $3.6b
Current Income Tax Expense (Benefit) $93.9m $234.3m $357.1m $84.4m ($349.3m) $342.4m $320.3m $547.1m $587.0m $630.7m $967.3m
Income Tax Expense (Benefit) ($37.0m) $553.4m ($438.5m) $113.0m ($1.9b) $677.3m $516.5m $428.3m $484.7m $690.5m $967.3m
Net Income (Loss) Attributable to Parent $1.4b
$364.5m -74.47%
$1.7b +355.00%
$855.4m -48.42%
($3.4b) -498.51%
$1.5b +145.18%
$1.7b +10.32%
$1.7b +2.74%
$1.5b -13.53%
$1.6b +2.99%
$2.6b +68.89%
Net Income (Loss) Attributable to Noncontrolling Interest $0 $0 ($42.5m) ($1.2m) $9.2m $4.7m ($32.3m) ($12.7m) $10.2m $13.6m $2.6b
Earnings Per Share, Basic $6.73 $1.67 $7.61 $4.07 ($16.65) $7.48 $8.15 $8.62 $7.60 $8.02 $13.53
Earnings Per Share, Diluted $6.32 $1.64 $7.53 $4.04 ($16.65) $7.39 $8.04 $8.53 $7.53 $7.96 $13.47
Income (Loss) from Continuing Operations, Per Basic Share $7
Income (Loss) from Continuing Operations, Per Diluted Share $6 $2 $8 $4 ($17) $7 $8 $9 $8 $8
Common Stock, Dividends, Per Share, Declared $0.00 $7.48 $8.15 $8.62 $2.04 $2.20
Basic (in shares) $212.2m $218.4m $217.9m $210.2m $204.8m $205.9m $208.5m $202.5m $198.5m $193.8m $194.0m
Diluted (in shares) $226.0m $221.6m $220.3m $211.8m $204.8m $208.5m $211.2m $204.6m $200.3m $195.2m $195.0m
Weighted Average Number of Shares Outstanding, Basic 212.2m 218.4m 217.9m 210.2m 204.8m 205.9m 208.5m 202.5m 198.5m 193.8m 194.0m
Weighted Average Number of Shares Outstanding, Diluted 226.0m 221.6m 220.3m 211.8m 204.8m 208.5m 211.2m 204.6m 200.3m 195.2m 195.0m
Additional Financial Items
Acquisition-related deal and integration expenses $19.2m $6.8m $43.2m $16.0m $117.0m $119.6m $139.7m $103.0m $291.0m
Amortization $152.5m $160.5m $181.2m $167.4m $110.9m $178.3m $307.3m $553.6m $663.5m $556.9m $489.1m
Business Combination, Acquisition Related Costs $19.2m $6.8m $43.2m $16.0m $117.0m $119.6m $139.7m $103.0m $291.0m
Depreciation $212.2m $237.1m $284.0m $295.0m $280.2m $326.8m $386.6m $410.3m $428.5m $494.1m $548.9m
Distribution, selling, and administrative $2.1b $2.1b $2.5b $2.7b $2.8b $3.6b $4.8b $5.3b $5.7b $6.5b
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount $113.5m
Goodwill impairment $0 $0 $59.7m $0 $0 $6.4m $75.9m $0 $418.0m $723.9m $723.9m
Goodwill, Impairment Loss $0 $0 $59.7m $0 $0 $6.4m $75.9m $0 $418.0m $723.9m $723.9m
Litigation and opioid-related expenses (credit), net $6.7b $272.6m $123.2m ($24.7m) $227.1m $60.7m
Net (income) loss attributable to noncontrolling interests $0 $0 ($42.5m) $1.2m ($9.2m) ($4.7m) $32.3m $12.7m ($10.2m) ($13.6m) $2.6b
Other loss (income), net ($5.0m) ($2.7m) $25.5m ($13.0m) ($1.6m) ($41.7m) ($27.4m) ($49.0m) $14.3m $78.7m
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $1.4b $0 $42.5m $1.2m $9.2m $4.7m $32.3m $12.7m $10.2m $13.6m
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent $0 $0 $42.5m $1.2m $9.2m $4.7m $32.3m $12.7m $10.2m $13.6m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.